Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Pfizer to Cut 300 Jobs as It Ends Alzheimer's, Parkinson's Quest

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

About 200 of the job cuts will be in Massachusetts, the remaining in Connecticut. Source: BioSpace

Continue ReadingPfizer to Cut 300 Jobs as It Ends Alzheimer's, Parkinson's Quest

New Jersey's Leading Pharma, LLC Scores $40M

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members. Source: BioSpace

Continue ReadingNew Jersey's Leading Pharma, LLC Scores $40M

What You Need to Know About Freenome

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called "liquid biopsy," in other words, blood.…

Continue ReadingWhat You Need to Know About Freenome

Teva, Alder BioPharma Forge $200M Anti-CGRP-Based Therapy Pact

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The agreement validates Teva’s IP and resolves Alder’s opposition to Teva’s European Patent No. 1957106 B1. Source: BioSpace

Continue ReadingTeva, Alder BioPharma Forge $200M Anti-CGRP-Based Therapy Pact

Struggling Acorda is Exploring a Sale, Shares Jump

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

Rumors that Acorda was considering a sale drove company stock up about 12 percent on Friday, Jan. 5, to hit $23.55. Source: BioSpace

Continue ReadingStruggling Acorda is Exploring a Sale, Shares Jump

Alder Announces $250M Committed Equity Financing

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

Alder intends to use the cash to fund payments under Alder’s European patent settlement and global license agreement with Teva announced today. Source: BioSpace

Continue ReadingAlder Announces $250M Committed Equity Financing

Rejected Again: Ablynx Turns Down Novo Nordisk's Sweetened $3.1B Bid

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The offers underline Novo Nordisk's interest in expanding beyond diabetes and into the rare diseases market. Source: BioSpace

Continue ReadingRejected Again: Ablynx Turns Down Novo Nordisk's Sweetened $3.1B Bid

Bristol-Myers to Take a $3B Tax Hit in Q4 2017

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace

Continue ReadingBristol-Myers to Take a $3B Tax Hit in Q4 2017

Besties Regeneron and Sanofi Add Another $1B to PD-1 I/O Deal

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The two companies struck the deal in 2015. Source: BioSpace

Continue ReadingBesties Regeneron and Sanofi Add Another $1B to PD-1 I/O Deal

Appeals Court Overturns Infringement Finding Against Apotex

  • Post author:Sam
  • Post published:January 5, 2018
  • Post category:Drug Industry Daily

The U.S. Court of Appeals for the Federal Circuit found that a district court was overly broad in its interpretation of patents in a lawsuit by a Teva subsidiary accusing…

Continue ReadingAppeals Court Overturns Infringement Finding Against Apotex
  • Go to the previous page
  • 1
  • …
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.